WO1997030092A2 - Hydrogels - Google Patents

Hydrogels Download PDF

Info

Publication number
WO1997030092A2
WO1997030092A2 PCT/GB1997/000420 GB9700420W WO9730092A2 WO 1997030092 A2 WO1997030092 A2 WO 1997030092A2 GB 9700420 W GB9700420 W GB 9700420W WO 9730092 A2 WO9730092 A2 WO 9730092A2
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogel
cross
linked
polysaccharide
chitosan
Prior art date
Application number
PCT/GB1997/000420
Other languages
French (fr)
Other versions
WO1997030092A3 (en
Inventor
Denis Keith Gilding
Kadem Gayad Al-Lamee
Original Assignee
Innovative Technologies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Technologies Limited filed Critical Innovative Technologies Limited
Priority to AU18025/97A priority Critical patent/AU1802597A/en
Publication of WO1997030092A2 publication Critical patent/WO1997030092A2/en
Publication of WO1997030092A3 publication Critical patent/WO1997030092A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Definitions

  • the present invention relates to hydrogels which are intended particularly, but
  • Hydrogels are water-swollen, three dimensionally cross-linked hydrophilic
  • polymers which are typically formed by cross-linking the polymer under aqueous conditions using a low amount of cross-linking agent so that a water-swollen, cross ⁇
  • the amount of cross-linking agent should not be too
  • the cross-links are usually either
  • (5) can (if required) also form carriers for antimicrobial agent or growth factors or
  • hydrogel comprising a cross-linked form of at least one water soluble polysaccharide selected from
  • Hydrogels in accordance with the invention are derived from the biocompatible and biodegradable polysaccharides identified under (i)-(ii) and may be
  • hydrogels comprised of the
  • cross-linked form of (i) and/or (ii) may optionally further comprise a cross-linked
  • Hydrogels in accordance with the invention are capable, when used as wound
  • hydrogels of the invention are quantities of fluid than current commercial hydrogels.
  • hydrogels (i) in accordance with the invention are those derived
  • galactomannan is a polysaccharide comprised of galactomannan residues
  • polymer of D-galactose and D-mannose examples of polymers comprising
  • galactomannan residues which may be used in accordance with the invention are those
  • guar gum derived from seed gums. e.g. guar gum and locust bean gum.
  • Hydrogels may be produced from the polysaccharide (i) by effecting cross ⁇
  • an alkali metal borate e.g. sodium
  • transition metal ions such as titanium
  • Hydrogels may be produced from the polysaccharide (i) by admixed with
  • the reaction is preferably effected at a pH
  • polysaccharide (i) is 1% to 6% w/v of the admixture, more preferably 1% to 5% on
  • Gels produced by this method may be either
  • the amount of the cross-linking agent may be up to about 0.2% w/v.
  • Hydrogels produced from polysaccharides (ii) may be obtained in a number of
  • chitosan derivatives such as carboxymethyl chitosan.
  • chitosan may be cross-linked using a dialdehyde which reacts with
  • dialdehyde is preferably of the formula
  • This cross-linking reaction is preferably effected in an acidic solution (e.g. at a pH of about 4) of the chitosan.
  • the amount of chitosan will be used in the range 1% to 6% w/v (e.g. about
  • dialdehyde 3% w/v
  • dialdehyde 3% w/v
  • This method is particularly suitable for the production of hydrogels in sheet form.
  • chitosan may be cross-linked using a dicarboxylic acid, preferably
  • polyalkylene glycol dicarboxylic acid is a polyalkylene glycol dicarboxylic acid (preferred molecular weight range 200
  • polysaccharide chains are cross-linked by diamide linkages.
  • chitosan is 1% to 6% w/v and the amount of dicarboxylic acid is 1 to 2% w/v.
  • compositions are suitable as amorphous hydrogels.
  • the chitosan may be reacted with a polymer having carboxylic acid
  • a suitable co-polymer is N-vinyl pyrrolidone acrylic acid
  • NDP-AA N-AA
  • hydrogel (preferably calcium) to form a hydrogel.
  • a hydrogel comprises 2%-
  • polysaccharides (i) or (ii) may further comprise a cross-linked form of a
  • polysaccharide (iii) i.e. pectin, pectic acid or pectate
  • pectin i.e. pectin, pectic acid or pectate
  • polysaccharide (iii) in the hydrogel is preferably in the range 2 to 4% w/v and
  • multivalent cation is present in an amount up to 0.2% w/v, e.g. 0.02% w/v.
  • the former may be
  • polysaccharide (i) and/or (ii) improves the adhesion of the latter in wounds as well as
  • polyhydric alcohol e.g. in an amount up to 20% w/v
  • the preferred polyhydric alcohol is propylene glycol
  • Fig 1 illustrates a part of the structure of guar gum.
  • Fig 2 illustrates the cross-linking of guar gum with a borate.
  • Fig 3 illustrates a hydrogel comprised of a mixture of (a) guar gum (chain 1 )
  • Fig 4 illustrates the structure of chitosan.
  • Fig. 5 illustrates the cross-linking of chitosan with glutaraldeyde.
  • Fig 6 illustrates chitosan modified by reaction with a N-vinylpyrrolidone
  • Figs 1 and 2 are generally self-explanatory, the former showing a portion of
  • FIG 3 there is schematically illustrated a product which
  • guar gum chain is represented by reference numeral 1 and is shown to be cross-linked
  • reference numeral 2 is shown to be cross-linked by calcium ions.
  • Fig 4 illustrates a portion of the structure of chitosan whereas Fig 5 illustrates
  • N-vinylpyrrolidone acrylic acid co-polymer More particularly, a portion of the
  • carboxylic acid groups on the co-polymer react with amino groups of the chitosan (to)
  • the modified chitosan may then be cross-linked using
  • the mixture was then homogenised with the aid of a high shear mixer.
  • hydrogel This hydrogel is cream coloured, thick, and paste-like. It was autoclaved at 121 °C for 15 minutes without apparent deterioration of the gel.
  • EDC Ethyl-3-(-3-Diethyl amino propyl) Carbodiimide
  • the gel was reacted further with a reducing agent such as sodium borohydride
  • Pectic acid (2g) was suspended in 1 1 ml of water and it was dissolved when the pH of the solution was raised to 3 after the addition of diluted
  • ion source e.g. 0.02g calcium chloride
  • a divalent ion source e.g. 0.024 g of calcium chloride
  • distilled water was homogenised with aid of high sheer mixture before the cast as a

Abstract

A hydrogel comprises a cross-linked form of at least one water soluble polysaccharide selected from (i) polysaccharides comprised of galactomannan residues, or (ii) chitosan or derivatives thereof.

Description

HYDROGELS
The present invention relates to hydrogels which are intended particularly, but
not exclusively, for use as wound dressings.
Hydrogels are water-swollen, three dimensionally cross-linked hydrophilic
polymers which are typically formed by cross-linking the polymer under aqueous conditions using a low amount of cross-linking agent so that a water-swollen, cross¬
linked polymer is produced. The amount of cross-linking agent should not be too
high otherwise the degree of cross-linking achieved will not allow the wa -r swelling
of the polymer necessary to produce the hydrogel. The cross-links are usually either
covalent or ionic bonds.
Hydrogels are used as wound dressings and have a number of advantages
which render them suitable for this purpose. In particular, they
(1) are particularly effective at promoting hydration, and therefore wound
debridement;
(2) have the ability to take up significant quantities of exudate in the management
of more heavily exuding wounds;
(3) arcyery thick putty-like, tacky and spreadable, and may be used for treatment
of open cavity wounds such as pressure ulcers and leg ulcers;
(4) retain their physical form as they absorb fluid; and
(5) can (if required) also form carriers for antimicrobial agent or growth factors or
any other biologically active molecules in order to speed up the healing process. Commercially available hydrogels do however suffer from a number of
disadvantages. In particular they do not always retain their physical form for a
sufficiently long period of time and as such do not absorb fluid for a sufficient time.
It is an object of the present invention to provide hydrogels which obviate or
mitigate the abovementioned disadvantages.
According to the present invention there is provided a hydrogel comprising a cross-linked form of at least one water soluble polysaccharide selected from
(i) polysaccharides comprised of galactomannan residues, or
(ii) chitosan or derivatives thereof.
Hydrogels in accordance with the invention are derived from the biocompatible and biodegradable polysaccharides identified under (i)-(ii) and may be
used as either amoφhous gels or sheet dressings. The hydrogels comprised of the
cross-linked form of (i) and/or (ii) may optionally further comprise a cross-linked
form of at least one water soluble polysaccharide selected from
(iii) pectin, pectic acid or pectate.
Hydrogels in accordance with the invention are capable, when used as wound
dressings, of retaining their physical form and absorbing fluid over substantial periods
of time when used in a hydrated wound. They are also capable of taking up larger
quantities of fluid than current commercial hydrogels. The hydrogels of the invention
also have the advantage being able to donate significant quantities of fluid to a dry
wound. One class of hydrogels (i) in accordance with the invention are those derived
from polysaccharides comprised of galactomannan residues (galactomannan is a
polymer of D-galactose and D-mannose). Examples of polymers comprising
galactomannan residues which may be used in accordance with the invention are those
derived from seed gums. e.g. guar gum and locust bean gum.
Hydrogels may be produced from the polysaccharide (i) by effecting cross¬
linking thereof with a borate ion e.g. provided by an alkali metal borate (e.g. sodium
borate). It is however also possible to use transition metal ions such as titanium
although borate is preferred.
Hydrogels may be produced from the polysaccharide (i) by admixed with
water and the desired cross-linking agent. The reaction is preferably effected at a pH
less than 9, preferably 6 to 8. ideally about pH = 7. Preferably the amount of the
polysaccharide (i) is 1% to 6% w/v of the admixture, more preferably 1% to 5% on
the same basis, e.g. about 4% w/v. Gels produced by this method may be either
spreadable or "rubbery"* depending on the concentration of the cross-linking agent
used. If it is desired to produce a spreadable product, then it is preferred to use at
most about 0.01% w/v of cross-linking agent. If it is desired to produce a sheet
hydrogel then the amount of the cross-linking agent may be up to about 0.2% w/v.
Hydrogels produced as described above from the polysaccharide (i) show no
thermal degradation when autoclaved at 120°C over 6 hours. This is believed to be
due to the use of borate as the cross-linking agent. Hydrogels produced from polysaccharides (ii) may be obtained in a number of
ways which will be described with specific reference to chitosan although these
methods may be applied to chitosan derivatives such as carboxymethyl chitosan.
Firstly, chitosan may be cross-linked using a dialdehyde which reacts with
amino groups on the chitosan molecule. The dialdehyde is preferably of the formula
OHC(CH2) CHO where n is 1 to 5, most preferably 3. This cross-linking reaction is preferably effected in an acidic solution (e.g. at a pH of about 4) of the chitosan.
Typically the amount of chitosan will be used in the range 1% to 6% w/v (e.g. about
3% w/v) and the dialdehyde will be used in the range 0.0005 to 0.01% w/v (e.g. about
0.001%). This method is particularly suitable for the production of hydrogels in sheet form.
Secondly, chitosan may be cross-linked using a dicarboxylic acid, preferably
using a carbodiimide as an activator. It is particularly preferred that the dicarboxylic
acid is a polyalkylene glycol dicarboxylic acid (preferred molecular weight range 200
to 2.000), most preferably a polyethylene glycol dicarboxylic acid. The cross-linking
proceeds via reaction of the carboxylic acid groups (on the cross-linking agent) with
amino groups on the chitosan with the aid of a water soluble carbodiimide so that the
polysaccharide chains are cross-linked by diamide linkages. Preferably the amount of
chitosan is 1% to 6% w/v and the amount of dicarboxylic acid is 1 to 2% w/v. Such
compositions are suitable as amorphous hydrogels.
Thirdly, the chitosan may be reacted with a polymer having carboxylic acid
groups along its chain to yield a modified chitosan having carboxylic pendant groups (attached to the "polymer" backbone). The reaction is preferably effected in the
presence of a carbodiimide. A suitable co-polymer is N-vinyl pyrrolidone acrylic acid
(NVP-AA). This modified chitosan may then be cross-linked using a multivalent ion
(preferably calcium) to form a hydrogel. Preferably such a hydrogel comprises 2%-
6% w/v chitosan or derivative thereof, 1% to 3% w/v N-vinyl pyrrolidone carboxylic
acid, copolymer, and 0.02% to 2% w/v calcium).
All of the above-described hydrogels based on the cross-linked form of
polysaccharides (i) or (ii) may further comprise a cross-linked form of a
polysaccharide (iii) (i.e. pectin, pectic acid or pectate) which has preferably been
cross-linked with a multivalent cation, preferably calcium. The amount of
polysaccharide (iii) in the hydrogel is preferably in the range 2 to 4% w/v and
multivalent cation is present in an amount up to 0.2% w/v, e.g. 0.02% w/v.
A particularly preferred embodiment of the invention relates to a gel which is
comprised of cross-linked polysaccharides (i) and (iii). In the gel, the former may be
cross-linked by borate and the latter cross-linked by a multivalent ion.
Incoφoration of a cross-linked polymer (iii) in a gel comprised of cross-linked
polysaccharide (i) and/or (ii) improves the adhesion of the latter in wounds as well as
to increase the exudate up-take in the wound by the gel.
All of the above described hydrogels may, with advantage, incoφorate a
polyhydric alcohol (e.g. in an amount up to 20% w/v) as a plasticiser and stabiliser to
improve the shelf-life of the gel. The preferred polyhydric alcohol is propylene glycol
The invention is illustrated by the accompanying drawings, in which: Fig 1 illustrates a part of the structure of guar gum.
Fig 2 illustrates the cross-linking of guar gum with a borate.
Fig 3 illustrates a hydrogel comprised of a mixture of (a) guar gum (chain 1 )
cross-linked with borate) and (b) pectic acid (chain 2) cross-linked with calcium ions.
Fig 4 illustrates the structure of chitosan.
Fig. 5 illustrates the cross-linking of chitosan with glutaraldeyde. and
Fig 6 illustrates chitosan modified by reaction with a N-vinylpyrrolidone
acrylic acid co-polymer, the modified chitosan then being cross-linked by means of
calcium ions which react with free carboxylic acid groups on the NVP-AA co¬
polymer chain.
Figs 1 and 2 are generally self-explanatory, the former showing a portion of
the structure of guar gum and the latter showing the manner in which guar gum chains
are cross-linked by borate ions.
Referring now to Fig 3, there is schematically illustrated a product which
comprises cross-linked guar gum and cross-linked pectic acid More particular!} . the
guar gum chain is represented by reference numeral 1 and is shown to be cross-linked
by borate ions (in the manner depicted in Fig. 2). The pectic acid chain is depicted by
reference numeral 2 and is shown to be cross-linked by calcium ions.
Fig 4 illustrates a portion of the structure of chitosan whereas Fig 5 illustrates
the cross-linking thereof using the dialdehyde OCH(CH2)3CHO, the cross-linking
being effected by reaction between ammo groups of chitosan and the aldehyde groups
of the cross-linking agent. Referring now to Fig. 6. there is illustrated the reaction product of chitosan
with N-vinylpyrrolidone acrylic acid co-polymer. More particularly, a portion of the
carboxylic acid groups on the co-polymer react with amino groups of the chitosan (to
produce amide linkages) to produce a modified chitosan have free carboxylic acid
groups on the polymer residue. The modified chitosan may then be cross-linked using
calcium ions as shown.
The invention is further illustrated by the following non-limiting Examples.
Example 1
Guar gum (4g) was dissolved in 81 ml distilled water and 15 ml propylene
glycol. The mixture was then homogenised with the aid of a high shear mixer. The
resulting product is a smooth and highly viscose mixture which was then cross-linked
after the addition of 0.0 lg sodium tetraborate anhydrous (borax) to produce a
hydrogel. This hydrogel is cream coloured, thick, and paste-like. It was autoclaved at 121 °C for 15 minutes without apparent deterioration of the gel.
Example 2
Guar gum (4g) was dissolved in 59 ml of distilled water containing 15 ml of
propylene glycol. Pectic acid (2g) was suspended in 20 ml distilled water and the pH
of this mixture was then adjusted with dilute sodium hydroxide to produce
homogenise solution. The latter solution was then added to guar gum solution and the
two components were mixed well using a high shear mixer. These two carbohydrates were then cross-linked after the addition of 0.02g of calcium chloride and 0.004g
borax respectively. The hydrogel produced by this technique is creamed coloured,
thick and paste-like. This gel was autoclaved for 15 minutes at 121 °C without
apparent deterioration.
Chitosan (3g) was dissolved in 80 ml distilled water containing 1ml acetic acid
and 15 ml propylene glycol. The resulting mixture was highly viscous and it was then cross-linked with a solution of polyethylene glycol dicarboxylic acid (0.5 g) and 1 -
Ethyl-3-(-3-Diethyl amino propyl) Carbodiimide (EDC) (0.3 g) in 5ml water. After
the addition of the latter solution a hydrogel was formed. This cross-linked gel was
clear, thick and spreadable.
Example 4
Chitosan (3g) was dissolved in 70 ml distilled water containing 6ml of IM
HCl and the mixture was then homogenised as described above. A solution of a
copolymer of N-vinyl pyrrolidone-acryiic acid (1.8 g) in 15 ml distilled water was
activated with EDC (30 mg) for 15 minutes at room temperature before it was added
to the chitosan mixture. This reaction was left going for 2 hours at room temperature
before the addition of calcium chloride (0.02 g) to form cross-linked hydrogel.
Propylene glycol (15 ml) was then added and the components were mixed well. The product was creamed coloured, thick, ticky and it was autoclaved without any
apparent deterioration.
Example 5
In this experiment 3 g of chitosan were dissolved in 81 ml water containing 1
ml of acetic acid and 15 ml of propylene glycol. The mixture was then homogenised
with the aid of a high shear mixer. The mixture was then cross-linked with 1 mg of
glutaraldehyde to form a gel. The resulting hydrogel was then autoclaved and the
colour of the gel became slightly yellow. To avoid the formation of this yellow
colour, the gel was reacted further with a reducing agent such as sodium borohydride
before autoclaving.
Example 6
Chitosan (3g) was dissolved in 68 ml of distilled water containing 1ml of
acetic acid and 15 ml of propylene glycol. The mixture was then homogenised with
the aid of a high shear mixer. Pectic acid (2g) was suspended in 1 1 ml of water and it was dissolved when the pH of the solution was raised to 3 after the addition of diluted
sodium hydroxide. The pectic acid solution was then added to chitosan solution and
the two polysaccharides mixed very well before they were cross-linked with a divalent
ion source (e.g. 0.02g calcium chloride) to form a spreadable gel.
Example 7 Carboxymethylchitosan (5g) was dissolved in 80 ml distilled water containing
15 ml of propylene glycol. The mixture was homogenised as described above and
then was cross-linked with a divalent ion source (e.g. 0.024 g of calcium chloride) to
form a spreadable gel.
Example 8
A mixture of 4% guar gum, 2% pectic acid, 15% propylene glycol and 79%
distilled water was homogenised with aid of high sheer mixture before the cast as a
film onto microporous nylon membrane. This film was then cross-linked after
immersion into a coagulation bath containing 0.2% calcium chloride and 0.01 %
borate to form a hydrogel sheet.

Claims

1. A hydrogel comprising a cross-linked form of at least one water soluble
polysaccharide selected from
(i) polysaccharides comprised of galactomannan residues, or
(ii) chitosan or derivatives thereof.
2. A hydrogel as claimed in claim 1 wherein the water soluble polysaccharide is
one comprised of galactomannan residues.
3. A hydrogel as claimed in claim 2 wherein the water soluble polysaccharide
comprises galactomannan residues and is derived from a seed gum.
4. A hydrogel as claimed in claim 3 wherein the seed gum is guar gum or locust bean gum.
5. A hydrogel as claimed in any one of claims 2 to 4 wherein the polysaccharide
is cross-linked with borate ions.
6. A hydrogel as claimed in claim 5 comprising up to 0.2% w/v of borate from
which the borate ions are derived.
7. A hydrogel as claimed in claim 6 comprising up to about 0.01 % w/v of borate.
8. A hydrogel as claimed in any one of claims 5 to 7 wherein the borate is an
alkali metal borate.
9. A hydrogel as claimed in any one of claims 2 to 4 wherein the polysaccharide
is cross-linked with transition metal ions.
10. A hydrogel as claimed in any one of claims 2 to 9 comprising 1 % to 6% w/v
of the polysaccharide.
1 1. A hydrogel as claimed in claim 10 comprising 1% to 5% w/v of the polysaccharide.
12. A hydrogel as claimed in claim 1 wherein the water soluble polysaccharide is
chitosan or a derivative thereof.
13. A hydrogel as claimed in claim 12 wherein the chitosan or derivative thereof is
cross-linked with a dialdehyde.
14. A hydrogel as claimed in claim 13 wherein the dialdehyde is of the formula
OHC(CH2)nCHO where n is 1 to 5, most preferably 3.
15. A hydrogel as claimed in claim 13 or 14 comprising 1% to 6% w/v of the
chitosan or derivative thereof and 0.001% to 1% w/v of the dialdehyde.
16. A hydrogel as claimed in claim 12 wherein the chitosan or chitosan derivative
is cross-linked with a dicarboxylic acid.
17. A hydrogel as claimed in claim 16 wherein the dicarboxylic acid is a
polyalkylene glycol dicarboxylic acid.
18. A hydrogel as claimed in claim 17 wherein the dicarboxylic acid is a
polyethylene glycol dicarboxylic acid.
19. A hydrogel as claimed in any one of claims 16 to 18 comprising 1 % to 6% w/v
of the polysaccharide and 0.5% to 2% of the dicarboxylic acid.
20. A hydrogel as claimed in claim 12 wherein the cross-linking is achieved by
reaction of the polysaccharide with a polymer having carboxylic acid groups along its chain to produce a modified polysaccharide having carboxylic pendant groups which
are cross-linked using a multivalent ion.
21. A hydrogel as claimed in claim 25 wherein the multivalent ion is calcium.
22. A hydrogel as claimed in claim 20 or 21 wherein the polymer having
carboxylic acid groups is N-vinylpyrrolidone acryiic acid.
23. A hydrogel as claimed in any one of claims 1 to 22 additionally comprising a cross-linked form of at least one water soluble polysaccharide selected from
(iii) pectin, pectic acid or pectate.
24. A hydrogel as claimed in claim 23 wherein the polysaccharide (iii) is cross¬
linked with a multivalent cation.
25. A hydrogel as claimed in claim 24 wherein the multivalent cation is calcium.
26. A hydrogel as claimed in claim 24 or 25 comprising 2 to 4% w/v of
polysaccharide (iii) cross-linked by up to 0.2% w/v of the multivalent cation.
27. A hydrogel as claimed in any one of claims 1 to 26 incoφorating a polyhydric
alcohol to improve the shelf-life of the gel.
28. A hydrogel as claimed in claim 27 wherein the polyhydric alcohol is present in
an amount up to 20% w/v of the hydrogel.
29. A hydrogel as claimed in claim 27 or 28 wherein the polyhydric alcohol is
propylene glycol.
PCT/GB1997/000420 1996-02-15 1997-02-14 Hydrogels WO1997030092A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18025/97A AU1802597A (en) 1996-02-15 1997-02-14 Hydrogels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9603146.3 1996-02-15
GBGB9603146.3A GB9603146D0 (en) 1996-02-15 1996-02-15 Hydrogels

Publications (2)

Publication Number Publication Date
WO1997030092A2 true WO1997030092A2 (en) 1997-08-21
WO1997030092A3 WO1997030092A3 (en) 1997-11-20

Family

ID=10788772

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000420 WO1997030092A2 (en) 1996-02-15 1997-02-14 Hydrogels

Country Status (3)

Country Link
AU (1) AU1802597A (en)
GB (1) GB9603146D0 (en)
WO (1) WO1997030092A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316506B2 (en) 1997-07-29 2001-11-13 Alcon Laboratories, Inc. Conditioning solutions for contact lens care
US6403609B1 (en) 1997-07-29 2002-06-11 Alcon Manufacturing, Ltd. Ophthalmic compositions containing galactomannan polymers and borate
US6413494B1 (en) * 1998-07-23 2002-07-02 Samyang Corporation Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides
US6495608B1 (en) 1997-07-29 2002-12-17 Alcon Manufacturing, Ltd. Methods of performing surgery with galactomannan polymers and borate
US6998509B1 (en) 1999-10-07 2006-02-14 Coloplast A/S Wound care device
US8101196B2 (en) 2001-06-26 2012-01-24 Biointeractions, Ltd. Polysaccharide biomaterials and methods of use thereof
WO2015200541A1 (en) 2014-06-24 2015-12-30 Bio-Rad Laboratories, Inc. Digital pcr barcoding
WO2017165620A1 (en) 2016-03-24 2017-09-28 Bio-Rad Laboratories, Inc. Use of gel beads to control droplet dispersion
WO2018118971A1 (en) 2016-12-19 2018-06-28 Bio-Rad Laboratories, Inc. Droplet tagging contiguity preserved tagmented dna
WO2018208632A1 (en) * 2017-05-12 2018-11-15 Corning Incorporated A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery
WO2018236918A1 (en) 2017-06-20 2018-12-27 Bio-Rad Laboratories, Inc. Mda using bead oligonucleotide
WO2019089959A1 (en) 2017-11-02 2019-05-09 Bio-Rad Laboratories, Inc. Transposase-based genomic analysis
CN109867729A (en) * 2019-03-05 2019-06-11 北京林业大学 Photoresponse type galactomannans hydrogel and preparation method thereof
WO2019152395A1 (en) 2018-01-31 2019-08-08 Bio-Rad Laboratories, Inc. Methods and compositions for deconvoluting partition barcodes
WO2020041293A1 (en) 2018-08-20 2020-02-27 Bio-Rad Laboratories, Inc. Nucleotide sequence generation by barcode bead-colocalization in partitions

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101613571B1 (en) 2013-07-02 2016-04-20 영남대학교 산학협력단 Method for manufacturing biodegradable polymer film and biodegradable polymer film for anti-adhesion

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2067214A (en) * 1979-12-17 1981-07-22 Colgate Palmolive Co Borated polysaccharide or polyvinyl alcohol and absorbent products
WO1992003172A1 (en) * 1990-08-17 1992-03-05 Sebapharma Gmbh & Co. Dressing system
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2067214A (en) * 1979-12-17 1981-07-22 Colgate Palmolive Co Borated polysaccharide or polyvinyl alcohol and absorbent products
WO1992003172A1 (en) * 1990-08-17 1992-03-05 Sebapharma Gmbh & Co. Dressing system
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAKROMOLEKULARE CHEMIE, MACROMOLECULAR CHEMISTRY AND PHYSICS, vol. 190, no. 5, 1 May 1989, BASEL CH, pages 951-960, XP000132505 GEORGE A.F. ROBERTS ET AL.: "The formation of gels by reaction of chitosan with glutaraldehyde." *

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316506B2 (en) 1997-07-29 2001-11-13 Alcon Laboratories, Inc. Conditioning solutions for contact lens care
US6403609B1 (en) 1997-07-29 2002-06-11 Alcon Manufacturing, Ltd. Ophthalmic compositions containing galactomannan polymers and borate
US6486215B2 (en) 1997-07-29 2002-11-26 Alcon Manufacturing, Ltd. Solutions for treating contact lenses
US6495608B1 (en) 1997-07-29 2002-12-17 Alcon Manufacturing, Ltd. Methods of performing surgery with galactomannan polymers and borate
US6583124B2 (en) 1997-07-29 2003-06-24 Alcon Manufacturing, Ltd. Ophthalmic compositions containing galactomannan polymers and borate
US6838449B2 (en) 1997-07-29 2005-01-04 Alcon Manufacturing, Ltd. Ophthalmic compositions containing galactomannan polymers and borate
US7169767B2 (en) 1997-07-29 2007-01-30 Alcon Manufacturing, Ltd. Ophthalmic compositions containing galactomannan polymers and borate
US6413494B1 (en) * 1998-07-23 2002-07-02 Samyang Corporation Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides
US6998509B1 (en) 1999-10-07 2006-02-14 Coloplast A/S Wound care device
US7141714B2 (en) 1999-10-07 2006-11-28 Coloplast A/S Wound care device
US8101196B2 (en) 2001-06-26 2012-01-24 Biointeractions, Ltd. Polysaccharide biomaterials and methods of use thereof
US9127091B2 (en) 2001-06-26 2015-09-08 Biointeractions, Ltd. Heparin coatings
WO2015200541A1 (en) 2014-06-24 2015-12-30 Bio-Rad Laboratories, Inc. Digital pcr barcoding
US11155809B2 (en) 2014-06-24 2021-10-26 Bio-Rad Laboratories, Inc. Digital PCR barcoding
WO2017165620A1 (en) 2016-03-24 2017-09-28 Bio-Rad Laboratories, Inc. Use of gel beads to control droplet dispersion
WO2018118971A1 (en) 2016-12-19 2018-06-28 Bio-Rad Laboratories, Inc. Droplet tagging contiguity preserved tagmented dna
WO2018208632A1 (en) * 2017-05-12 2018-11-15 Corning Incorporated A cross-linked shear thinning fluid with tunable rheology for 3d bioprinting and drug delivery
WO2018236918A1 (en) 2017-06-20 2018-12-27 Bio-Rad Laboratories, Inc. Mda using bead oligonucleotide
WO2019089959A1 (en) 2017-11-02 2019-05-09 Bio-Rad Laboratories, Inc. Transposase-based genomic analysis
EP4180534A1 (en) 2017-11-02 2023-05-17 Bio-Rad Laboratories, Inc. Transposase-based genomic analysis
WO2019152395A1 (en) 2018-01-31 2019-08-08 Bio-Rad Laboratories, Inc. Methods and compositions for deconvoluting partition barcodes
EP4324962A2 (en) 2018-01-31 2024-02-21 Bio-Rad Laboratories, Inc. Methods and compositions for deconvoluting partition barcodes
WO2020041293A1 (en) 2018-08-20 2020-02-27 Bio-Rad Laboratories, Inc. Nucleotide sequence generation by barcode bead-colocalization in partitions
EP4249651A2 (en) 2018-08-20 2023-09-27 Bio-Rad Laboratories, Inc. Nucleotide sequence generation by barcode bead-colocalization in partitions
CN109867729A (en) * 2019-03-05 2019-06-11 北京林业大学 Photoresponse type galactomannans hydrogel and preparation method thereof
CN109867729B (en) * 2019-03-05 2020-12-01 北京林业大学 Photoresponse type galactomannan hydrogel and preparation method thereof

Also Published As

Publication number Publication date
WO1997030092A3 (en) 1997-11-20
AU1802597A (en) 1997-09-02
GB9603146D0 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
WO1997030092A2 (en) Hydrogels
US5502042A (en) Methods and compositions for treating wounds
US5093319A (en) Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
US4994277A (en) Use of xanthan gum for preventing adhesions
US6756363B1 (en) Solutions and films of glycated chitosan
US5116824A (en) Biomaterial comprising a composite material of a chitosan derivative and collagen derivative
ES2221070T3 (en) ADHESIVE COMPOSITION WITH A MACROMOLECULAR BASE OF A POLYDEHYDE AND PROCEDURE FOR COLLAGEN RETICULATION.
ES2253827T3 (en) USE OF HIALURONIC ACID DERIVATIVES IN THE PREPARATION OF BIOMATERIALS.
KR930004655B1 (en) Compositions containing derivatives of chitin for preventing adhesion
US20090035356A1 (en) Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings
EP1003526B1 (en) Covalently linked n,o-carboxymethylchitosan and uses thereof
GB2314842A (en) Protein/oxidised regenerated cellulose complexes
JP2009529926A5 (en)
CA2153947A1 (en) Sterile gel compositions for wound treatment
US20090227537A1 (en) Sulfated polysaccharides and uses thereof in medical treatment
CA2264647A1 (en) Fragmented polymeric hydrogels for adhesion prevention and their preparation
GB2275686A (en) Swellable wound dressing materials
US7345117B1 (en) Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
JP2003252936A (en) Temperature-responsive material and composition comprising the same
CN115926200A (en) Preparation method and application of enzyme-catalyzed double-crosslinked polymer composite hydrogel material
CN1539515A (en) Biomaterial for preventing accretion after surgery and preparation method
US20080254015A1 (en) Gel Composition of Citrus Complex Carbohydrates Cross-Linked with Cellulose Derivate
CN114767925A (en) Fluorescent pH-sensitive antibacterial hydrogel dressing and preparation method and application thereof
CA2470639A1 (en) Preparation for wound healing and prevention of bandage adhesion to the wound
CN114917400B (en) Polylysine antibacterial tissue adhesive and application thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: JP

Ref document number: 97529110

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase